Yasuo Terauchi

36PUBLICATIONS
74CO-AUTHORS
PharmacogenomicsElectrochemical energy storage and conversionPharmaceutical delivery technologiesBiomechanicsAboriginal and Torres Strait Islander medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|May 29, 2026
Cardiovascular Risk Reduction With Tirzepatide, a Dual GIP/GLP-1 Agonist, in Patients With Type 2 Diabetes Mellitus.

|Oct 03, 2025
Regulatory Roles of IGF2R in Insulin Secretion and Adaptive β-Cell Proliferation.

Jun Shirakawa, Dario F De Jesus, Takahiro Tsuno

|Mar 08, 2025
Safety of iGlarLixi in Japanese People with Type 2 Diabetes: A Post-marketing Database Study.

Hideaki Kaneto, Makiko Hatanaka, Yukiko Morimoto

|Feb 23, 2024
Efficacy of StepAdd, a Personalized mHealth Intervention Based on Social Cognitive Theory to Increase Physical Activity Among Patients With Type 2 Diabetes Mellitus: Protocol for a Randomized Controlled Trial.

Kayo Waki, Yuya Tsurutani, Hironori Waki

|Feb 16, 2024
Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan.

Daisuke Yabe, Munehide Matsuhisa, Yoko Takahashi

|Feb 22, 2023
Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study.

Hideaki Miyoshi, Munehide Matsuhisa, Daisuke Yabe

Pageof 6

Frequent Collaborators

6 joint publications

Jun Shirakawa

5 joint publications

Yoko Takahashi

4 joint publications

Hideaki Miyoshi

4 joint publications

Daisuke Yabe